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Influence of the emetic reflex on vasopressin release in man. The
mechanisms underlying the frequent association of nausea and
vomiting with elevations of plasma vasopressin (PAVp) were stud-
ied in man and rat. After oral water loads (N = 16), plasma os-
molality fell in all human subjects and was associated with a de-
cline in PAVP in 14 asymptomatic human subjects. In 2 human
subjects, nausea occurred and was associated with increases in
PAVP, without changes in blood pressure. During ethanol infusion(N = 28), PAVP was suppressed unless nausea supervened. In 4
nauseated human subjects, PAVP escaped from ethanol inhibition
and rose to levels 10 times basal, despite the absence of hemo-
dynamic changes. Apomorphine, a potent dopamine agonist and
emetic agent, was administered to human volunteers in doses of
7 to 24 pg/kg. There was no increase in PAVP in 3 human subjects
who remained asymptomatic (7 to 16 gIkg). Ten human subjects
experienced nausea after 16 pg/kg, which was followed shortly
by marked increases in PAVP. Emesis occurred in 5 human sub-
jects given 16 to 24 pg/kg, and was followed by PAVP levels simi-
lar to those seen with nausea alone. In 7 human subjects from the
nausea group, the repeat study (16 gIkg) after pretreatment with
dopamine antagonist (haloperidol, N = 4; fluphenazine, N = 3)
resulted in complete blockage of apomorphine-induced AVP re-
lease. In rats, which lack an emetic reflex, apomorphine in doses
of 200 pg/kg induced only slight increases in PAVP when com-
pared to the response to 16 zg/kg in man. These studies indicate
that stimulation of the emetic reflex results in AVP-release in
man. Nausea-mediated AVP release supervenes over con-
comitant osmolar or pharmacologic (ethanol) inhibition.
Influence du réftexe de vomissement sur Ia liberation de vaso-
pressine chez l'homme. Les mécanismes qui sous-tendent
l'association fréquente de nausées et vomissements, d'une part,
et l'augmentation de la vasopressine plasmatique (PAy?), d'autre
part, ont été étudiés chez l'homme et Ic rat. Après une charge en
eau par voie orale (N = 16), l'osmolalité plasmatique a diminué
chez tous les sujets et cela a été associé a une baisse de PAy?
chez les 14 sujets indemnes de symptOmes. Deux sujets ont eu
des nausées, associCes a l'augmentation de PAy?, sans modifica-
tions de la pression artérielle. Au cours de Ia perfusion d'éthanol(N = 28), PAy? a été nulle sauf dans les cas ou des nausées ont
été observées. Chez 4 sujets ayant des nausées, PAy? a échappC
a l'inhibition par l'éthanol et augmenté a des valeurs égales a 10
fois Ia basale malgré l'absence de modifications hémodyna-
miques. L'apomorphine, agoniste puissant de Ia dopamine et
émétique a ëté administrée a des volontaires a des doses de 7 a
24 pg/kg. II n'y a pas eu d'augmentation de PAY? chez 3 sujets qui
n'ont pas eu de symptomes (7 a 16 pg/kg). Dix sujets ont eu des
nausées aprés 16 tg/kg, ce qui a éte suivi de peu par une aug-
mentation importante de PAY?. Cinq sujets ont vomi après 16 a 24
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pg/kg, ce qui a été suivi de valeurs de PAY? semblables a celles
observées aprés les nausées san vomissements. Chez 7 sujets du
groupe atteint de nausées, Ia répétition de l'étude avec 16 hg/kg
sous un antagoniste de Ia dopamine (halopéridol, N = 4; flu-
phénazine, N = 3) a permis d'observer le blocage complet de la
liberation d'AVP induite par l'apomorphine. Chez les rats, qui
n'ont pas de réflexe de vomissement, l'apomorphine, a la dose
de 200 pg/kg, n'a déterminé qu'une faible augmentation de PAVP
par comparaison avec la réponse de l'homme a 16 pg/kg. Ces
résultats indiquent que Ia stimulation du réflexe de vomissement
determine une liberation d'AVP chez l'homme. La liberation
d'AVP qui a Ia nausée pour médiateur apparait malgré
l'inhibition osmolaire ou pharmacologique (alcool) con-
comittante.
Plasma osmolality and effective circulating blood
volume are the major regulators of plasma vaso-
pressin (AVP). Other factors, including age, alco-
hol, and nicotine, have been shown to influence
AVP secretion [1]. Nausea and vomiting frequently
complicate clinical studies of AVP secretion, partic-
ularly studies that use cigarette smoking, ingestion
of water loads, and infusion of alcohol or hypoten-
sive agents, and nausea and vomiting are also com-
monly present in clinical situations associated with
inappropriate antidiuresis. The present studies were
designed to clarify the possible contributions of the
emetic reflex to AVP secretion. We have measured
plasma AVP levels in a variety of physiologic cir-
cumstances associated with nausea and vomiting
and have compared plasma AVP response to apo-
morphine-induced stimulation of the emetic reflex
in man and rat, an animal known to have an in-
complete emetic apparatus.
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Methods
Apomorphine studies. Eighteen studies were per-
formed in 16 healthy young volunteer subjects of
either sex. The subjects were carefully screened to
exclude hepatic, renal, or cardiac disease or the ad-
ministration of any medications. All studies were
performed with the subjects recumbent at 8:00 A.M.
after nothing by mouth for 10 to 12 hours. A scalp-
vein needle was placed in an antecubital vein. After
a 30-mm equilibration period, blood samples were
drawn at 5-mm intervals for determining basal
AVP and osmolality. After the s.c. administration
of apomorphine in doses varying from 7 to 24 gIkg,
we obtained blood samples for measuring AVP and
osmolality at regular intervals for 45 mm. Blood
pressure and pulse were carefully monitored
throughout the study. Seven subjects experiencing
nausea without vomiting after 16 kg of apomor-
phine were selected for repeat study after pre-
treatment with dopamine antagonists. In 3 of these
subjects, fluphenazine (1.25 mg, i.m.) was given 1
hour before apomorphine injection, and in the other
4 subjects haloperidol (4 mg) was administered by
mouth 8 hours prior to the apomorphine injection.
In the fluphenazine-apomorphine studies, two
blood samples for measuring AVP were drawn be-
fore and at 55 and 60 mm after fluphenazine admin-
istration.
One study was performed under conditions of
forced water diuresis to evaluate the biologic ef-
fectiveness of AVP released after apomorphine ad-
ministration. Sixty minutes before injecting the apo-
morphine, we began an i.v. infusion of 0.45% so-
dium chloride at a rate of 0.25 mi/kg/mm. Free
water clearance was measured in four successive
15-mm periods before the administration of 16 jig!
kg of apomorphine and at 40 and 60 mm after the
injection.
Animal studies. The influence of apomorphine on
plasma AVP was studied in male Sprague-Dawley
rats, each weighing 200 to 230 g. The rat was chosen
as an experimental animal because it lacks an emet-
ic reflex [2]. Twenty minutes after injecting apomor-
phine in s.c. doses of 20 to 200 j.g/kg, we sacrificed
by guillotine these unanesthesized rats, and we col-
lected the blood emanating from the vessels of the
neck for measuring plasma AVP, osmolality, and
blood hematocrit. Doses of 200 p,g/kg have been
shown previously in our laboratory not to result in
changes in blood pressure in the rat.
Ethanol infusions. In a study of the influence of
age on AVP response to intravenous ethanol, 28
carefully screened healthy male subjects from
across the adult age range received intravenous eth-
yl alcohol (15% volume/volume) at the rate of 375
mg/m2/min for 1 hour after overnight dehydration
[3]. Blood pressure was monitored throughout the
study. Samples of venous blood were collected un-
der basal conditions and at frequent intervals during
the infusion and for the following 4 hours for mea-
surement of blood ethanol, plasma osmolality, and
AVP.
Water load studies. Standard oral water loads (20
cc/kg) were administered to 16 subjects after an
overnight dehydration. After two venous blood
samples were collected for measuring basal os-
molality and AVP level, subjects were asked to in-
gest the water load gradually over a period no great-
er than 30 mm. Venous blood samples for plasma
osmolality and AVP were obtained at 30-mm inter-
vals. Blood pressure and pulse were monitored
throughout the studies.
In all studies, AVP was measured in plasma as
previously described [4]. All protocols were ap-
proved by the Committee on Human Studies, and
written informed consent was obtained prior to all
studies.
Results
Apomorphine studies. Plasma AVP response to
apomorphine was related to the presence or ab-
sence of symptoms of nausea and vomiting (Table
1). Three subjects given 7 to 16 j.g/kg apomorphine
remained asymptomatic throughout the study, and
in these subjects there was no increase in plasma
AVP. Nausea occurred in the remaining 15 studies
and was associated with vomiting in five cases. In
all instances, there was a dramatic rise in plasma
AVP coincident with or slightly after the onset of
symptoms. Subject 2 received 16 pg/kg on two oc-
casions. In one study there were no symptoms, and
there was no increase in AVP. In the repeat study,
nausea occurred and was associated with a marked
increase in AVP release. There was no difference in
plasma AVP response between the nausea group
and vomiting group. Although apomorphine in-
duced a slight fall in mean arterial pressure, the ini-
tial and maximum decrease (—4.4 3.8%) occurred
3 mm after plasma AVP had risen to 100 pg/mI. In
addition, previous studies of hypotension-related
AVP release, including posture studies and trimeth-
aphan infusions, indicate that 15% to 20% reduc-
tions in mean arterial blood pressure induce in-
creases in plasma AVP to levels of 10 to 20 pg/mi
[5], as compared to the levels of over 200 pglml seen
in these studies (Fig. 1). Thus, the hemodynamic
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effects of apomorphine were inadequate to explain
the marked increase in vasopressin release. There
was no change in plasma osmolality in any of the
apomorphine studies.
Because apomorphine is a potent dopamine agon-
ist, studies were repeated in individuals who devel-
oped nausea without vomiting after pretreatment
with one of two dopamine antagonists (Fig. 2). The
plasma AVP response to apomorphine, as well as
symptoms, was completely blocked by pre-
treatment with haloperidol or fluphenazine. Basal
AVP levels, pulse, and blood pressure were un-
changed by pretreatment with either agent.
In the subject given apomorphine under condi-
tions of forced water diuresis, nausea was followed
by elevation of plasma AVP to a peak level of 49 pg/
ml. This AVP elevation occurred despite the hy-
poosmolality and volume expansion induced by the
infusion of 0.45% sodium chloride and was associat-
ed with a marked antidiuretic effect as manifested
by the transition from a moderate water diuresis to
negative free water clearance (Fig. 3). In this study,
the plasma AVP response was less prominent and
slightly delayed when compared to that seen in the
studies performed after overnight dehydration.
Because rats do not vomit and thus have an in-
complete emetic apparatus, the influence of apo-
morphine on AVP was studied in the rat. As is
shown in Fig. 4, the increase in plasma AVP after
apomorphine administration in the rat is slight de-
spite doses up to 10 times that which resulted in
striking AVP elevations in man. At the higher dose
levels (200 gIkg), yawning and licking movements
were elicited.
Water load studies. In a series of 16 healthy vol-
unteer subjects administered oral water loads, two
subjects complained of nausea during the study. In
1 subject, nausea occurred 5 mm into the experi-
ment, by which time she had already ingested ap-
proximately half the water load, and was associated
with an increase in plasma AVP from the initial un-
detectable levels (< 0.05 pglml) to 1.1 pglml. In this
subject, nausea may have been related to acute gas-
tric distention. In the other subject, nausea oc-
curred half an hour after completion of ingestion of
the water load, and was associated with elevation of
AVP from basal level of 1.8 pg/mi to a peak of 6.5
pg/ml despite the fact that plasma osmolality had
fallen from basal level of 292 to 287 mOsm/kg. In
the remaining asymptomatic subjects, plasma Os-
Table!. Relation of apomorphine dose, symptoms, and plasma AVP response in human subjects
Subject no. Apomorphinep.g/ml Symptoms
Plasma AVP,pglml
—10
mm
0
mm
6
mm
9
mm
15
mm
30
mm
45
mm
1
2
3
mean
SEM
7
16
14
None
None
None
2.0
1.9
2.4
2.1
1.2
—
2.0
1.8
1.9
1.6
1.7
1.6
1,5
1.4
1.5
1.6
1.8
2.0
1.8
2.1
2.8
2.4
2.4
2.5
2.5
2.6
2.5
2
4
5
6
7
8
9
10
11
12
mean
16
16
16
16
16
16
16
16
16
16
N
N
N
N
N
N
N
N
N
N
1.4
1.1
2.7
4.0
1.3
0.9
2.3
—
8.8
3.2
2.8
2.4
1.2
2.2
2.7
0.9
1.4
0.5
15
8.1
3.7
3.8
24
0.7
5.3
3.5
2.2
2.2
11
47
18.2
5.5
12.0
86
169
89
—
16
230
93
233
15
10.2
105.0
306
525
127
>50
105
360
37
158
474
180
232.0
61
530
28
177
278
120
12
30
287
64
159.0
16
555
20
335
40
80
4
20
53
19
114.0
3
13
14
15
16
mean
SEM
24
16
16
21
16
V
V
V
V
V
1.4
2.7
0.8
1.3
7.4
2.7
1.2
2.2
2.8
1.6
1.5
10.1
3.6
1.6
22
1.5
1.3
22
41
17.6
7.5
42
1.2
1.4
258
885
238.0
168.0
—
14
13
—
—
—
—
353
3.6
101
20
50
105.5
64.0
14
3.5
13
8.6
38
15.4
5.9
N = nausea; V = nausea and vomiting.
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molality fell and was associated with a gradual and
significant decline in plasma AVP.
Ethanol infusions. Ethanol is generally acknowl-
edged to have an inhibitory effect on the secre-
tion of AVP. Nausea or vomiting occurred in 4 of
the 28 subjects who participated in the ethanol in-
fusion study. As we have previously reported [3],
the rise in blood ethanol concentration was associ-
ated with a prompt and statistically significant fall in
plasma AVP in 22 subjects without blood pressure
changes in whom the only symptoms were those of
mild intoxication. Contrasting with the plasma AVP
response seen in these subjects was the response of
the 4 subjects who became nauseated. In these cas-
es, the initial ethanol-induced decline in plasma
AVP from the basal levels of 5 pg/mi was inter-
rupted by marked transient elevations of plasma
AVP to peak levels between 28 and 50 pg/ml. These
bursts of AVP release were associated with the on-
set of nausea or vomiting and occurred in the ab-
sence of changes in blood pressure. In one patient,
there were two distinct waves of nausea and AVP
elevation that were clearly temporally related.
Peaks in plasma AVP such as associated with nau-
sea and vomiting in these subjects were not ob-
served in any of the asymptomatic subjects.
Discussion
These studies indicate that stimulation of the
emetic reflex in man results in the prompt release of
large amounts of biologically active vasopressin. It
would appear that nausea is required for this effect,
vomiting is not necessary, and that the AVP release
is independent of osmolar or hemodynamic stimuli.
Nausea-mediated stimulation of AVP release super-
venes over concomitant osmolar, or pharmacologic
(ethanol) inhibition.
The central medullary component of the emetic
apparatus consists of an emetic center in the region
of the dorsal reticular formation and a separate re-
gion in the area postrema, termed the chemorecep-
tor trigger zone (CTZ). The CTZ is sensitive to apo-
morphine and also receives input from the labyrinth
via the cerebellum and vestibular nuclei. The emet-
ic center receives direct input from the gastrointes-
tinal tract, the heart, and cerebral cortex, as well as
input relayed via the CTZ. Efferent pathways from
the emetic center include somatic and visceral
nerves innervating the throat, esophagus, dia-
phragm, abdominal musculature, and involuntary
muscles of the intestines. The specific anatomic
pathways connecting the emetic center and the su-
praoptic nucleus have not been identified. Evidence
supporting brainstem input into AVP-producing
cells can be found in studies of the monkey, cat, and
dog, in which electrical stimulation of the midbrain
reticular formation has excitatory effects on anti-
dromically identified single supraoptic and para-
ventricular cells [6].
Reflex emesis such as induced by apomorphine
requires integrity of the entire medullary apparatus,
with CTZ activation leading to stimulation of the
emetic center. Nonreflex (direct) emetic stimuli di-
rectly affect the emetic center and do not require an
intact CTZ [2]. The blockade of apomorphine-in-
duced AVP release by pretreatment with dopamine
antagonists indicates that dopaminergic pathways
participate in apomorphine-induced stimulation of
AVP secretion. The contributions of dopaminergic
transmission at the level of CTZ, emetic center, and
supraoptic nucleus, individually or in concert, are
uncertain. A role for dopaminergic transmission at
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Fig. 1.Relationship of plasma vasopressin to decreases in blood
pressure during apomorphine-induced nausea and/or vomiting
(*). Shown for comparison are the values observed in another
group of healthy adults during hypotension induced by the in-
fusion of triimethaphan (.) [4] or standing immediately after
phlebotomy (0) [5]. In the two latter groups, plasma vasopressin
and percent decrease in mean arterial pressure show a significant
positive correlation (r = 0.88) described by a log-linear function
(log y = 0.048x + 0.252). In the subjects given apomorphine,
these two variables are not correlated.
Emetic reflex and vasopressin release in man 733
A B
I
>
Fluphenazine+ apomorphine
Haloperidol + apomorphine
20 20
10
_________
— 10
9 0-———?
—10 0 3 6 9 12 15 20 45
-10 0 3 6 9 12 15 20 30 45
Time, rn/n Time, rn/n
Fig. 2. Influence of pretreatment with dopamine antagonist of plasma AVP response to apomorphine (16 kg). A AVP response is
shown for four human subjects who developed nausea without vomiting and repeat studies in the same subjects at same apomorphine
dose after pretreatment with haloperidol (4 mg, per Os) 8 hours prior to study. B AVP response is shown for three human subjects who
developed nausea without vomiting and repeat studies in the same subjects at same apomorphine dose after pretreatment with fluphena-
zine (1.25 mg, i.m.) 1 hour prior to apomorphine. None of the subjects developed nausea during the repeat studies.
the emetic center is supported by previous reports
that other dopamine antagonists such as chioro-
promazine are effective in preventing nausea or
vomiting related to local effects on the gastrointesti-
nal tract [7]. Support for a dopamine receptor in the
supraoptic nucleus is provided by studies showing
that injection of dopamine or apomorphine into the
lateral cerebral ventricles of the intact rat results in
AVP release, as does in vitro incubation of the rat
hypothalamus with these substances [8]. The
marked insensitivity of the rat to apomorphine-in-
duced vasopressin release, however, makes it very
likely that the major component of the AVP re-
sponse in man is mediated via the emetic apparatus.
The species specificity of this emetic-center-me-
diated regulation of AVP release is indicated by the
markedly reduced capacity of apomorphine, over a
broad dose range, to elicit an increase in plasma
AVP in rats, which are known to lack the emetic
reflex. The almost total absence of apomorphine-in-
duced AVP release in rats supports the concept that
apomorphine-induced AVP release in man is medi-
ated via the emetic center rather than other dopami-
nergic pathways and provides the first evidence of a
+10.0
$8.0
+6.0
+4.0
0
—1.0
0.0
E
50
—45 —10 0 15 30
Time, rn/n
Fig. 3. Relation of apomorphine-induced nausea and AVP re-
lease to free water clearance (CH2O) in a human subject under-
going water diuresis. Volume expansion and water diuresis were
induced by i.v. infusion of 0.45% sodium chloride at 0.25 mlIkgI
mm starting 60 mm prior to injection of 16 pg/kg apomorphine.
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15
Time, mm
Fig. 4. Comparison of plasma AVP response to apomorphine in
man and the rat. Human subjects who developed nausea after 16
sg/kg are denoted by closedcircles (.). Rats given 20 beg/kg apO-
morphine are denoted by open squares (a). Rats given 200 sg/kg
are denoted by closed squares (U). Rats were male (200 to 230 g
body wt). Each data point represents three rats. Asterisks in-
dicate P < 0.05 compared to isotonic saline control (control data
not shown). Values plotted represent mean SEM.
major interspecies difference in the control of AVP
secretion.
The prominent negative free water clearance that
developed after apomorphine administration in the
subject studied under conditions of forced water
diuresis indicates the biologic activity of at least
some of the radioimmunoassayable AVP released
after apomorphine. It is of interest to note in this
study that the plasma AVP peak was delayed and of
less magnitude than it was in the studies that used
apomorphine administration after overnight dehy-
dration. This may represent an attenuation of apo-
morphine-induced AVP release by the hypoosmola-
lity and slight volume expansion induced by the in-
fusion of 0.45% sodium chloride. Similarly, nausea-
related AVP levels were lower in the presence of
the inhibitory influence of ethanol or after oral wa-
ter loads than the levels associated with apomor-
phine-induced nausea.
The increase in plasma AVP following apomor-
phine-induced symptoms was more sustained in the
subgroup who experienced nausea as compared
with those who vomited. The physiologic mecha-
nisms underlying nausea and vomiting are poorly
differentiated from one another, and we can offer no
explanation for this observation. It is possible that
the AVP release associated with nausea and vomit-
ing was actually related to the nonspecific stress
that accompanies these symptoms. This is, how-
ever, unlikely in view of the recent evidence from
two laboratories that, contrary to general belief,
several nociceptive stimuli, including pain, ether-
ization, centrifugation, and water immersion, uni-
formly fail to raise plasma AVP in conscious rats [1,
91. Moreover, there are no published studies in man
regarding the influence of nociceptive stimuli on
plasma AVP.
The mechanism of nausea in the water load stud-
ies is unclear. In the subject who became nauseated
5 mm after the onset of the study, and who already
had consumed half the total water load in that 5-mm
period, acute gastric dilatation may have played a
major role. In the alcohol studies, it may be that the
direct toxic effect of alcohol on the gastric lining
was responsible for the nausea and vomiting.
The presence of emetic-center-mediated release
of vasopressin must be considered in clinical stud-
ies of AVP metabolism in which nausea super-
venes, as well as in laboratory studies in animals
other than the rat.
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